- Active ingredient:
- Pregabalin 225 mg
- Pharmaceutical form:
- Hard capsule: Hard gelatin capsules marked “1,” with an opaque orange-red cap and an opaque white body, containing a white or nearly white powder
- Route of administration:
- It is taken by mouth. Discontinuation of pregabalin treatment: If it becomes necessary to discontinue pregabalin treatment for neuropathic pain, epilepsy, generalized anxiety disorder, or fibromyalgia, it is recommended to taper off the medication gradually over a period of at least one week.